Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 05.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
05.02.Slam Corp. and Lynk Global, Inc. Announce Definitive Business Combination Agreement130NEW YORK--(BUSINESS WIRE)--Lynk Global, Inc. ("Lynk"), the world's leading satellite-direct-to-standard-phone ("sat2phone") telecoms provider, and Slam Corp. (NASDAQ: SLAM), a special purpose acquisition...
► Artikel lesen
05.02.Shiseido Americas Completes Acquisition of Dr. Dennis Gross Skincare239TOKYO--(BUSINESS WIRE)--Shiseido Company, Limited (The Prime Market of the Tokyo Stock Exchange: 4911) ("Shiseido", "Company") today announced that its subsidiary, Shiseido Americas Corporation...
► Artikel lesen
05.02.Cabot Corp Reports First Quarter Fiscal 2024 Results132BOSTON--(BUSINESS WIRE)--Cabot Corporation (NYSE: CBT) today announced results for its first quarter of fiscal year 2024. Key Highlights Reinforcement Materials segment EBIT of $129 million...
► Artikel lesen
05.02.Premier, Inc. Reports Fiscal-Year 2024 Second-Quarter Results119 CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 second quarter...
► Artikel lesen
05.02.Skyline Champion Announces Third Quarter Fiscal 2024 Results242TROY, Mich.--(BUSINESS WIRE)--Skyline Champion Corporation (NYSE: SKY) ("Skyline Champion") today announced financial results for its third quarter ended December 30, 2023 ("fiscal 2024"). Third...
► Artikel lesen
05.02.Fabrinet Announces Second Quarter Fiscal Year 2024 Financial Results424BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment...
► Artikel lesen
05.02.Kilroy Realty Corporation Reports Fourth Quarter Financial Results137LOS ANGELES--(BUSINESS WIRE)--Kilroy Realty Corporation (NYSE: KRC) today reported financial results for its fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year...
► Artikel lesen
05.02.Golub Capital BDC, Inc. Announces Fiscal Year 2024 First Quarter Financial Results with Second Consecutive Quarter of Highest-Ever Adjusted Net Investment Income147NEW YORK--(BUSINESS WIRE)--Golub Capital BDC, Inc., a business development company (Nasdaq: GBDC), today announced its financial results for its first fiscal quarter ended December 31, 2023. Except...
► Artikel lesen
05.02.Flexsteel Industries, Inc. Reports Strong Fiscal Second Quarter 2024 Results and Announces Manufacturing Network Optimization Actions197DUBUQUE, Iowa--(BUSINESS WIRE)--Flexsteel Industries, Inc. (NASDAQ: FLXS) ("Flexsteel" or the "Company"), one of the largest manufacturers, importers, and marketers of residential furniture products...
► Artikel lesen
05.02.Vertex Reports Fourth Quarter and Full Year 2023 Financial Results121BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2023 and provided...
► Artikel lesen
05.02.Palantir Reports Its Fifth Consecutive Quarter of GAAP Profitability; Fourth Quarter GAAP EPS of $0.04101DENVER--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Q4 2023 Highlights GAAP net...
► Artikel lesen
05.02.Kimball Electronics Reports Q2 Results; Company Updates Guidance for Fiscal 2024158JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the second quarter of fiscal 2024. ...
► Artikel lesen
05.02.AECOM reports first quarter fiscal 2024 results102DALLAS--(BUSINESS WIRE)--AECOM (NYSE:ACM), the world's trusted infrastructure consulting firm, today reported first quarter fiscal 2024 results. First Quarter Fiscal 2024 (from...
► Artikel lesen
05.02.Rambus Reports Fourth Quarter and Fiscal Year 2023 Financial Results250SAN JOSE, Calif.--(BUSINESS WIRE)--Rambus Inc. (NASDAQ:RMBS), a provider of industry-leading chips and IP making data faster and safer, today reported financial results for the fourth quarter ended...
► Artikel lesen
05.02.Intevac Announces Fourth Quarter and Full Year 2023 Financial Results127SANTA CLARA, Calif.--(BUSINESS WIRE)--Intevac, Inc. (Nasdaq: IVAC), a leading supplier of thin-film processing systems, today reported financial results for the fiscal fourth quarter and year ended...
► Artikel lesen
05.02.Chegg Reports 2023 Fourth Quarter and Full Year Financial Results199SANTA CLARA, Calif.--(BUSINESS WIRE)--Chegg, Inc. (NYSE:CHGG), the leading student-first connected learning platform, today reported financial results for the three and twelve months ended December...
► Artikel lesen
05.02.Amkor Technology Reports Financial Results for the Fourth Quarter and Full Year 2023163TEMPE, Ariz.--(BUSINESS WIRE)--Amkor Technology, Inc. (Nasdaq: AMKR), a leading provider of semiconductor packaging and test services, today announced financial results for the fourth quarter and...
► Artikel lesen
05.02.Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 5 February 2024277Regulatory News: Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) ("PSH") today announced that it has purchased, through PSH's agent, Jefferies International Limited ("Jefferies"), the...
► Artikel lesen
05.02.Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi)321Tafasitamab is approved in combination with lenalidomide for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), and is currently in Phase 3 trials for multiple indications Incyte...
► Artikel lesen
05.02.Vertex Pharmaceuticals Incorporated: Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis373- Treatment with the once-daily vanza triple CFTR modulator regimen met all primary and key secondary endpoints in two randomized controlled trials in people with CF ages 12 years and older ...
► Artikel lesen
Seite:  Weiter >>